Could Mixed CAR T‐Cell Products and Overlapping Patients Overestimate the Risk of HLH With Tisagenlecleucel?

Wenqiang Chen, Qiuhong Ma, Zhenzhen Chen
American Journal of Hematology · Wiley · 2026-11-06 · DOI: 10.1002/ajh.70493

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles